{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/a4c5de36-8260-4222-8e38-ff997dc73436/62d15720054be60012dcc69d?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e856e989985776/1657886249310-ca8e653ac98ede8794cb17a4fe0e036e.jpeg?height=200","description":"<p>On this week's show, we get the breakdown on GSK spinoff Haleon which is set to list next week.</p><p><br></p><p>Then Arthur Sants takes a fascinating dive into the business of psychedelic drugs, and whether they can be the future of depression and anxiety treatment.</p><p><br></p><p>Finally, the panel look into the potential European gas crisis, with the threat of Russian pipelines being turned off hanging over the continent.</p><p><br></p><p>Dan Jones host Alex Newman, Alex Hamer, Mark Robinson and Arthur Sants.</p><p><br></p><p>Timestamps:</p><p>00:00 - Intro</p><p>01:00 - News roundup</p><p>02:49 - GSK spinoff Haleon listing previewed</p><p>13:24 - Can psychedelics be the future of anxiety treatment?</p><p>23:16 - A looming European gas crisis?</p>","author_name":"Investors' Chronicle"}